Hepatitis G virus infection in hepatitis C virus-positive patients co-infected or not with hepatitis B virus and/or human immunodeficiency virus

Journal of Viral Hepatitis

Volumn 5, Issue 2, 1998, Pages 123-130

  Thiers, V ^a   Pol, S ^b   Persico, T ^a   Carnot, F ^c   Zylberberg, H ^b   Berthelot, P ^b   Brechot C ^a,b,d   Nalpas, B ^b,d  

^a INSTITUT PASTEUR   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c Hopital Laennec   (France)

^d INSERM   (France)

Author keywords

Co infection; HBV; HCV; Hepatitis; HGV; HIV

Indexed keywords

ADULT; ARTICLE; COMORBIDITY; FEMALE; HEPATITIS B; HEPATITIS G VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS HEPATITIS;

ADULT; FEMALE; FLAVIVIRIDAE; GENOTYPE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C ANTIBODIES; HEPATITIS C, CHRONIC; HEPATITIS, VIRAL, HUMAN; HIV; HIV INFECTIONS; HUMANS; MALE; PREVALENCE; RETROSPECTIVE STUDIES; RNA, VIRAL;

EID: 0031856452     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1998.00092.x     Document Type: Article

References (24)

1. Simons JN, Leary TP, Dawson GJ et al. Isolation of novel virus-like sequences associated with human hepatitis. Nature Med 1995; 1: 564-569.
2. Leary TP, Muerhoff AS, Simons JN et al. Sequence and genomic organization of GBV-C: a novel member of the Flaviridae associated with human non-A-E hepatitis. J Med Virol 1996; 48: 60-67.
3. Linnen J, Wages J, Zhang-Keck Z-Y et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505-508.
4. Masuko K, Mitsui T, Iwano K et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996; 334: 1485-1490.
5. Alter HJ, Nakatsuji Y, Meldoper J et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336: 747-754.
6. Alter MJ, Gallagher M, Morris T. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. N Engl J Med 1997; 336: 741-746.
7. Pilot-Matias TJ, Carrick RJ, Coleman PF et al. Expression of the GB virus C E2 glycoprotein using the Semliki Forest virus vector system and its utility as a serologic marker. Virology 1996; 225: 282-292.
8. Tacke M, Kiyosawa K, Stark K et al. Detection of antibodies to a putative hepatitis G virus envelope protein. Lancet 1997; 349: 318-320.
9. Hadziyannis S, Wages J, Kim JP et al. Frequency of viraemia with a new hepatitis virus (HGV) in patients with liver disease and in groups at high risk of exposure to blood and blood products. J Hepatol 1995; 23: 78 (abstr).
10. Aikawa T, Sugai Y, Okamoto H. Hepatitis G infection in drug abusers with chronic hepatitis C. N Engl J Med 1996; 334: 195-196 (letter).
11. Tanaka E, Alter HJ, Nakatsuji Y et al. Effect of hepatitis G virus infection on chronic hepatitis C. Ann Intern Med 1996; 125: 740-743.
12. Zylberberg H, Pol S. Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections. Clin Infect Dis 1996; 23: 117-125.
13. Thiers V, Jaffredo F, Tuveri R, Chodan N, Bréchot C. Development of a simple restriction fragment length polymorphism (RFLP) based assay for HCV genotyping and comparative analysis with genotyping and serotyping tests. J Virol Methods 1997; 65: 9-17.
14. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocynate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
15. Knodell R, Ishak K, Black W et al. Formulation and application of a numerical scoring system for assessing the histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1: 431-435.
16. Esteban JI, Esteban R, Viladomiu L et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2: 294-297.
17. Mortimer PP, Cohen BJ, Litton PA et al. Hepatitis C virus. Lancet 1989; 2: 798.
18. Van der Hoeck JAR, Van Haastrecht HJA, Goudsmit J, De Wolf F, Coutinho RA. Prevalence, incidence and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis 1990; 162: 823-826.
19. Heringlake S, Osterkamp S, Trautwein C et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet 1996; 348: 1626-1629.
20. Zaidi Y, Chapman CS, Myint S. Aplastic anaemia after HGV infection. Lancet 1996; 348: 471-472.
21. Bralet MP, Roudot-Thoraval J, Pawlotsky JM et al. Histopathologic impact of GB virus C infection on chronic hepatitis C. Gastroenterology 1997; 112: 188-192.
22. Pontisso P, Ruvoletto MG, Fattovitch G et al. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 1993; 105: 1529-1533.
23. Koike K, Yasuda K, Yotsuyanagi Y et al. Dominant replication of either virus in dual infection with hepatitis viruses B and C. J Med Virol 1995; 45: 236-239.
24. Eyster ME, Fried MW, DiBisceglie AM, Godert JJ. Increasing HCV RNA in hemophiliacs: relation to HIV infection and liver disease. Blood 1994; 84: 1020-1023.